Plasma levels of anticonvulsant agents may become subtherapeutic during cisplatin therapy. Cisplatin produces cumulative nephrotoxicity that is potentiated by aminoglycosides.
Sign up for Free to continue reading
Asia's one-stop resource for medical news, clinical reference and education
Sign Out
